Skip to main content
. 2019 Dec 9;58(Suppl 7):vii68–vii74. doi: 10.1093/rheumatology/kez295

Fig. 1.

Fig. 1

Frequency and type of joints involvement in patients experiencing rheumatic irAEs with CPI therapy CPI: checkpoint inhibitors; irAEs: immune-related adverse events.